AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35850533 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise, 20-60 min per session, three times per week for twelve weeks
Number of subjects: 73
Study 35850533 — intervention group
Group type: COMPARATOR
Intervention: Exercise education (control group)
Number of subjects: 73
Study 34118700 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive reappraisal (CR)
Number of subjects: 50
Study 34118700 — intervention group
Group type: COMPARATOR
Intervention: Sitting quietly (Control)
Number of subjects: 50
Study 32445735 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 158
Study 32445735 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 158
Study 34587794 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning model for predicting final infarct volume
Number of subjects: 228
Study 34587794 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning model for predicting individual infarct growth rates
Number of subjects: 228
Study 33159976 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT-539313 200 mg b.i.d.
Number of subjects: 58
Study 33159976 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 32405550 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone gel plus herbal extract gel
Number of subjects: 48
Study 32405550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 36315949 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor‐aspirin
Number of subjects: 6378
Study 36315949 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel‐aspirin
Number of subjects: 6378
Study 32475444 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal diet + 200 mg/kg chitosan (CS200)
Number of subjects: 320
Study 32475444 — intervention group
Group type: COMPARATOR
Intervention: Basal diet (control)
Number of subjects: 320
Study 32557838 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor skills At Playtime (MAP) intervention
Number of subjects: 46
Study 32557838 — intervention group
Group type: COMPARATOR
Intervention: Control (outdoor free play)
Number of subjects: 46
Study 35291272 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistant starch 2 (RS2) at doses of 10, 15, and 20 g/d
Number of subjects: 11
Study 35291272 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugarcane bagasse at doses of 5, 10, and 15 g/d
Number of subjects: 11
Study 35291272 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of RS2 and sugarcane bagasse at doses of 20, 25, and 30 g/d
Number of subjects: 11
Study 35291272 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 11
Study 35291272 — intervention group
Group type: EXPERIMENTAL
Intervention: IBS patients
Number of subjects: 11
Study 35291272 — intervention group
Group type: EXPERIMENTAL
Intervention: RS2 ≤ 20 g/d
Number of subjects: 11
Study 32485759 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) for up to 30 minutes
Number of subjects: 40
Study 32485759 — intervention group
Group type: COMPARATOR
Intervention: Control (no additional intervention)
Number of subjects: 40
Study 34133809 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) during painful dental procedures requiring local anesthesia
Number of subjects: 54
Study 34133809 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (without VR) during painful dental procedures requiring local anesthesia
Number of subjects: 54
Study 34133809 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) during non-painful dental procedures
Number of subjects: 54
Study 34133809 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (without VR) during non-painful dental procedures
Number of subjects: 54
Study 32542352 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery Intervention Condition (IC)
Number of subjects: 105
Study 32542352 — intervention group
Group type: COMPARATOR
Intervention: Active behavioral Control Condition (CC)
Number of subjects: 105
Study 35775872 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysport + Profhilo gel
Number of subjects: 19
Study 35775872 — intervention group
Group type: COMPARATOR
Intervention: Dysport
Number of subjects: 19
Study 33610251 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone, cefoxitin, clindamycin, and imipenem
Number of subjects: 62
Study 33610251 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 62
Study 33610251 — intervention group
Group type: EXPERIMENTAL
Intervention: Nim genes
Number of subjects: 62
Study 33610251 — intervention group
Group type: EXPERIMENTAL
Intervention: cfiA gene
Number of subjects: 62
Study 33610251 — intervention group
Group type: EXPERIMENTAL
Intervention: ermF gene
Number of subjects: 62
Study 33610251 — intervention group
Group type: EXPERIMENTAL
Intervention: cepA gene
Number of subjects: 62
Study 32732105 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg dinoprostone vaginally
Number of subjects: 160
Study 32732105 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaginally
Number of subjects: 160
Study 35442180 — intervention group
Group type: EXPERIMENTAL
Intervention: Good CPAP adherence (⩾4 h/night)
Number of subjects: 1803
Study 35442180 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe OSA (AHI >40 events/h)
Number of subjects: 1803
Study 35442180 — intervention group
Group type: COMPARATOR
Intervention: Usual care/poor CPAP adherence
Number of subjects: 1803
Study 35442180 — intervention group
Group type: EXPERIMENTAL
Intervention: OSA (AHI ⩾15 events/h)
Number of subjects: 1803
Study 33742678 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilization (to sit in a chair) and standardized breathing exercises (n = 73)
Number of subjects: 214
Study 33742678 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilization (to sit in a chair) only (n = 76)
Number of subjects: 214
Study 33742678 — intervention group
Group type: COMPARATOR
Intervention: Control (n = 65)
Number of subjects: 214
Study 32415472 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT) with a prescribed dose of 36.25 Gy in 5 fractions, twice a week
Number of subjects: 28
Study 33236702 — intervention group
Group type: EXPERIMENTAL
Intervention: HiFive program (6-week handwashing campaign targeting social and emotional motivators)
Number of subjects: 196
Study 33236702 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 196
Study 34543665 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine plus oxybutynin (Reb‐Oxy)
Number of subjects: 16
Study 34543665 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 32772733 — intervention group
Group type: EXPERIMENTAL
Intervention: Two measles vaccinations (at inclusion and at 9 months of age)
Number of subjects: 237
Study 32772733 — intervention group
Group type: COMPARATOR
Intervention: One measles vaccination (at 9 months of age)
Number of subjects: 237
Study 36377601 — intervention group
Group type: EXPERIMENTAL
Intervention: ixazomib+cyclophosphamide+dexamethasone (ICd)
Number of subjects: 0
Study 36377601 — intervention group
Group type: COMPARATOR
Intervention: ixazomib+dexamethasone (Id)
Number of subjects: 0
Study 34304028 — intervention group
Group type: EXPERIMENTAL
Intervention: 360° video VRET incorporating stimuli of audiences (360°Audience), n = 17
Number of subjects: 51
Study 34304028 — intervention group
Group type: EXPERIMENTAL
Intervention: 360° video VRET incorporating stimuli of empty rooms (360°Empty), n = 16
Number of subjects: 51
Study 34304028 — intervention group
Group type: COMPARATOR
Intervention: No treatment control, n = 18
Number of subjects: 51
Study 33139834 — intervention group
Group type: EXPERIMENTAL
Intervention: Downhill running (DR) for 30 minutes at 70% vVO2peak
Number of subjects: 27
Study 33139834 — intervention group
Group type: COMPARATOR
Intervention: Level running (LR) for 60 minutes at 70% vVO2peak
Number of subjects: 27
Study 34380963 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution-Focused Therapy (SFT)
Number of subjects: 124
Study 34454099 — intervention group
Group type: EXPERIMENTAL
Intervention: Unadjusted analyses
Number of subjects: 0
Study 34454099 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted analysis
Number of subjects: 0
Study 34635989 — intervention group
Group type: EXPERIMENTAL
Intervention: Vilaprisan 1 mg single dose
Number of subjects: 48
Study 34635989 — intervention group
Group type: EXPERIMENTAL
Intervention: Vilaprisan 5 mg single dose
Number of subjects: 48
Study 34635989 — intervention group
Group type: EXPERIMENTAL
Intervention: Vilaprisan 15 mg single dose
Number of subjects: 48
Study 34635989 — intervention group
Group type: EXPERIMENTAL
Intervention: Vilaprisan 1 mg/day for 28 days
Number of subjects: 48
Study 34635989 — intervention group
Group type: EXPERIMENTAL
Intervention: Vilaprisan 5 mg/day for 28 days
Number of subjects: 48
Study 34635989 — intervention group
Group type: COMPARATOR
Intervention: Placebo (single dosing)
Number of subjects: 48
Study 34635989 — intervention group
Group type: COMPARATOR
Intervention: Placebo (multiple dosing)
Number of subjects: 48
Study 34270830 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric leg extension exercise breaks
Number of subjects: 17
Study 34270830 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking breaks
Number of subjects: 17
Study 34270830 — intervention group
Group type: COMPARATOR
Intervention: Control (no breaks)
Number of subjects: 17
Study 32997710 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-way text messaging (2wT)
Number of subjects: 2
Study 32997710 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SoC)
Number of subjects: 2
Study 35343844 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication identification device (intervention unit)
Number of subjects: 70
Study 35343844 — intervention group
Group type: COMPARATOR
Intervention: Standard medication administration (control unit)
Number of subjects: 70
Study 33446053 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesenchymal stromal cells (MSCs)
Number of subjects: 25
Study 32376491 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab treatment
Number of subjects: 761
Study 32376491 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 761
Study 36151961 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of transcervical Foley catheter and sublingual misoprostol
Number of subjects: 0
Study 36151961 — intervention group
Group type: COMPARATOR
Intervention: Sublingual misoprostol alone
Number of subjects: 0
Study 33576037 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal amplifier (PA; Williams Sound Pocketalker 2.0)
Number of subjects: 133
Study 33576037 — intervention group
Group type: COMPARATOR
Intervention: Control group (no personal amplifier)
Number of subjects: 133
Study 36202740 — intervention group
Group type: EXPERIMENTAL
Intervention: MND-2119 2 g/day
Number of subjects: 122
Study 36202740 — intervention group
Group type: EXPERIMENTAL
Intervention: MND-2119 4 g/day
Number of subjects: 122
Study 34431233 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Very Low-Energy Diet (VLED)
Number of subjects: 164
Study 34431233 — intervention group
Group type: COMPARATOR
Intervention: Standard Dietary Intervention (SDI)
Number of subjects: 164
Study 34431233 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite of adverse pregnancy outcomes
Number of subjects: 164
Study 32423584 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir (200 mg on day 1 followed by 100 mg on days 2-10)
Number of subjects: 237
Study 32423584 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir (for patients with symptom duration of 10 days or less)
Number of subjects: 237
Study 32423584 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 237
Study 32423584 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 237
Study 36395177 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 papers from highly-ranked institutions
Number of subjects: 78085
Study 36395177 — intervention group
Group type: COMPARATOR
Intervention: COVID-19 papers from less reputed institutions
Number of subjects: 78085
Study 36395177 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-blind review procedure
Number of subjects: 78085
Study 36395177 — intervention group
Group type: COMPARATOR
Intervention: Double-blind review procedure
Number of subjects: 78085
Study 36395177 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 papers first authored by women
Number of subjects: 78085
Study 36395177 — intervention group
Group type: COMPARATOR
Intervention: COVID-19 papers first authored by men
Number of subjects: 78085
Study 34463700 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal (n = 202)
Number of subjects: 412
Study 34463700 — intervention group
Group type: COMPARATOR
Intervention: Standard care with conventional low tidal volume ventilation (n = 210)
Number of subjects: 412
Study 34463700 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal
Number of subjects: 412
Study 34463700 — intervention group
Group type: COMPARATOR
Intervention: Standard care with conventional low tidal volume ventilation
Number of subjects: 412
Study 34516959 — intervention group
Group type: EXPERIMENTAL
Intervention: Transitional, tailored, progressive rehabilitation intervention
Number of subjects: 349
Study 34516959 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 349
Study 34521260 — intervention group
Group type: EXPERIMENTAL
Intervention: Atogepant 10 mg
Number of subjects: 873
Study 34521260 — intervention group
Group type: EXPERIMENTAL
Intervention: Atogepant 30 mg
Number of subjects: 873
Study 34521260 — intervention group
Group type: EXPERIMENTAL
Intervention: Atogepant 60 mg
Number of subjects: 873
Study 34521260 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 873
Study 34521260 — intervention group
Group type: EXPERIMENTAL
Intervention: Atogepant (all doses)
Number of subjects: 873
Study 33514681 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-collected vaginal swabs
Number of subjects: 12
Study 33625476 — intervention group
Group type: EXPERIMENTAL
Intervention: Semaglutide, 2.4 mg
Number of subjects: 611
Study 33625476 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 611
Study 32608001 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenomethionine (SM) at 0.4 mg/kg diet (SM2)
Number of subjects: 120
Study 32608001 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenomethionine (SM)
Number of subjects: 120
Study 32608001 — intervention group
Group type: COMPARATOR
Intervention: Sodium selenite (SS) at 0.2 mg/kg diet (SS1)
Number of subjects: 120
Study 34581859 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal ultrasound (AUS)
Number of subjects: 86
Study 34581859 — intervention group
Group type: COMPARATOR
Intervention: Abdominal X-ray (AXR)
Number of subjects: 86
Study 34581859 — intervention group
Group type: EXPERIMENTAL
Intervention: Urgent surgery
Number of subjects: 86
Study 33231130 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance use prevention intervention
Number of subjects: 0
Study 33231130 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally centered strategies
Number of subjects: 0
Study 33231130 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based recruitment methods
Number of subjects: 0
Study 33231130 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up survey strategies
Number of subjects: 0
Study 33514408 — intervention group
Group type: EXPERIMENTAL
Intervention: EMDR + active-MtCS
Number of subjects: 45
Study 33514408 — intervention group
Group type: COMPARATOR
Intervention: EMDR + sham-MtCS
Number of subjects: 45
Study 33514408 — intervention group
Group type: COMPARATOR
Intervention: Waiting List
Number of subjects: 45
Study 36060658 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 120
Study 32342848 — intervention group
Group type: EXPERIMENTAL
Intervention: DPIV+AS03B (0-1 month regimen)
Number of subjects: 140
Study 32342848 — intervention group
Group type: EXPERIMENTAL
Intervention: DPIV+AS03B (0-1-6 month regimen)
Number of subjects: 140
Study 32342848 — intervention group
Group type: EXPERIMENTAL
Intervention: DPIV+AS03B (0-3 month regimen)
Number of subjects: 140
Study 32342848 — intervention group
Group type: EXPERIMENTAL
Intervention: DPIV+AS03B
Number of subjects: 140
Study 32342848 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 36054562 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa/carbidopa 400/100 mg plus opicapone 50 mg
Number of subjects: 24
Study 36054562 — intervention group
Group type: COMPARATOR
Intervention: Levodopa/carbidopa 500/125 mg without opicapone
Number of subjects: 24
Study 33518452 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT) at 2 atm absolute for 2 hours × 20 sessions
Number of subjects: 20
Study 33518452 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 20
Study 33518452 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT)
Number of subjects: 20
Study 33518452 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects who developed CAS or required stenting
Number of subjects: 20
Study 33518452 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects who developed ACR
Number of subjects: 20
Study 35106809 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised unfractionated heparin (UFH)
Number of subjects: 0
Study 35106809 — intervention group
Group type: COMPARATOR
Intervention: Standard care or placebo (depending on the study design)
Number of subjects: 0
Study 33252169 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Completion (SC) of the Edmonton Symptom Assessment Scale (ESAS)
Number of subjects: 126
Study 33252169 — intervention group
Group type: COMPARATOR
Intervention: Assisted Completion (AC) by a nurse
Number of subjects: 126
Study 33252169 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Completion (SC) with nurse review
Number of subjects: 126
Study 33252169 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower literacy (REALM) score and shortness of breath
Number of subjects: 126
Study 35535057 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin (550 mg twice daily)
Number of subjects: 132
Study 35535057 — intervention group
Group type: COMPARATOR
Intervention: Norfloxacin (400 mg once daily)
Number of subjects: 132
Study 33781125 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on Brazilian Dietary Guidelines (16 hours of training)
Number of subjects: 4
Study 33781125 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 4
Study 34514739 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 576
Study 34514739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 576
Study 33684643 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 45
Study 33684643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 33684643 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate and Placebo
Number of subjects: 45
Study 33938613 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish consumption (6% of diet)
Number of subjects: 26
Study 33938613 — intervention group
Group type: EXPERIMENTAL
Intervention: Soda consumption (14% of diet)
Number of subjects: 26
Study 33223425 — intervention group
Group type: EXPERIMENTAL
Intervention: RestoreX Penile Traction Therapy (PTT)
Number of subjects: 110
Study 33223425 — intervention group
Group type: COMPARATOR
Intervention: No therapy (control)
Number of subjects: 110
Study 34266853 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery as part of multimodality treatment
Number of subjects: 66
Study 34266853 — intervention group
Group type: COMPARATOR
Intervention: No surgery as part of multimodality treatment
Number of subjects: 66
Study 33136243 — intervention group
Group type: EXPERIMENTAL
Intervention: EORTC QLQ-C30 questionnaire
Number of subjects: 1107
Study 36307755 — intervention group
Group type: EXPERIMENTAL
Intervention: M-TAPA block performed bilaterally after the induction of general anesthesia
Number of subjects: 68
Study 36307755 — intervention group
Group type: EXPERIMENTAL
Intervention: M-TAPA block
Number of subjects: 68
Study 36307755 — intervention group
Group type: COMPARATOR
Intervention: Control group (no block performed)
Number of subjects: 68
Study 34245234 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation (IR) for 10 days post-surgery
Number of subjects: 158
Study 34245234 — intervention group
Group type: COMPARATOR
Intervention: Home program alone
Number of subjects: 158
Study 34245234 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation (IR)
Number of subjects: 158
Study 34245234 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient rehabilitation (IR) and home program
Number of subjects: 158
Study 33078599 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel plus carboplatin (TC)
Number of subjects: 166
Study 33078599 — intervention group
Group type: COMPARATOR
Intervention: Irinotecan plus cisplatin (CPT-P)
Number of subjects: 166
Study 35912312 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy and occupation-based bilateral upper limb training
Number of subjects: 0
Study 35912312 — intervention group
Group type: COMPARATOR
Intervention: Conventional occupational therapy and occupation-based bilateral upper limb training
Number of subjects: 0
Study 34197166 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive parent-child images
Number of subjects: 1093
Study 34197166 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative parent-child images
Number of subjects: 1093
Study 34197166 — intervention group
Group type: COMPARATOR
Intervention: Control images
Number of subjects: 1093
Study 32921367 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine, staged, angiographically guided nonculprit lesion PCI
Number of subjects: 0
Study 32921367 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment of nonculprit lesions
Number of subjects: 0
Study 32656955 — intervention group
Group type: EXPERIMENTAL
Intervention: HRpre images generated by DCGAN
Number of subjects: 224
Study 32656955 — intervention group
Group type: EXPERIMENTAL
Intervention: HRpost images generated by DCGAN
Number of subjects: 224